India's pharmaceutical market is witnessing a surge in new drug launches, particularly in the oncology segment, fueled by a ...

Shares of solid tumor concern Zymeworks Inc. have barely budged since the company obtained its first approval. Click here to ...

A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super ...

MONDAY, Feb. 3, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic ...

2. Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies.

MONDAY, Feb. 3, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone ...

We found that Acuity, Auto-Owners, Axis, Federated Insurance, The Hartford, Nationwide and Sentry are the best commercial auto insurance companies. Each scored five out of five stars in our analysis.

If you're a business owner, your car insurance won't cover a car, truck, van or other vehicle you use for work That's when you need commercial auto insurance. It provides the same protections as ...

Commercial real estate investing offers an attractive avenue for those looking to diversify their portfolios with income-producing assets. Unlike residential real estate, commercial properties ...

Commercial auto insurance policies provide specific protection for vehicles used in commercial or business settings. According to quotes we received, business owners can expect to pay at least $ ...

Enhertu has been a major commercial success for AstraZeneca and Daiichi Sankyo, generating $3bn in revenue in 2023, as per the company financials. According to GlobalData’s Pharma Intelligence ...